{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,20]],"date-time":"2026-09-20T17:15:22Z","timestamp":1789924522889,"version":"4.0.1"},"reference-count":36,"publisher":"Public Library of Science (PLoS)","issue":"10","license":[{"start":{"date-parts":[[2018,10,10]],"date-time":"2018-10-10T00:00:00Z","timestamp":1539129600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0204973","type":"journal-article","created":{"date-parts":[[2018,10,10]],"date-time":"2018-10-10T18:26:13Z","timestamp":1539195973000},"page":"e0204973","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":26,"title":["Phase I study of onapristone, a type I antiprogestin, in female patients with previously treated recurrent or metastatic progesterone receptor-expressing cancers"],"prefix":"10.1371","volume":"13","author":[{"given":"Paul H.","family":"Cottu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacques","family":"Bonneterre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Varga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mario","family":"Campone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandra","family":"Leary","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne","family":"Floquet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dominique","family":"Berton-Rigaud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie-Paule","family":"Sablin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne","family":"Lesoin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keyvan","family":"Rezai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fran\u00e7ois M.","family":"Lokiec","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine","family":"Lhomme","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacques","family":"Bosq","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alice S.","family":"Bexon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erard M.","family":"Gilles","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan","family":"Proniuk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Veronique","family":"Dieras","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David M.","family":"Jackson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander","family":"Zukiwski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antoine","family":"Italiano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2018,10,10]]},"reference":[{"issue":"1","key":"ref1","first-page":"77","article-title":"Progesterone receptor isoforms in normal and malignant breast","author":"PA Mote","year":"2007","journal-title":"Ernst Schering Found Symp Proc"},{"key":"ref2","first-page":"94","article-title":"Progesterone receptor action: translating studies in breast cancer models to clinical insights","volume":"630","author":"CA Lange","year":"2008","journal-title":"Adv Exp Med Biol"},{"issue":"1","key":"ref3","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1210\/er.2012-1043","article-title":"Progesterone action in endometrial cancer, endometriosis, uterine fibroids, and breast cancer","volume":"34","author":"JJ Kim","year":"2013","journal-title":"Endocr Rev. f\u00e9vr"},{"issue":"1","key":"ref4","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1002\/1097-0142(19840101)53:1<113::AID-CNCR2820530120>3.0.CO;2-F","article-title":"Heterogeneity and progesterone-receptor distribution in endometrial adenocarcinoma","volume":"53","author":"R Mortel","year":"1984","journal-title":"Cancer"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1146\/annurev.physiol.69.031905.160319","article-title":"Integration of rapid signaling events with steroid hormone receptor action in breast and prostate cancer","volume":"69","author":"CA Lange","year":"2007","journal-title":"Annu Rev Physiol"},{"issue":"4","key":"ref6","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1002\/pros.1108","article-title":"Progesterone receptor expression in human prostate cancer: correlation with tumor progression","volume":"48","author":"H Bonkhoff","year":"2001","journal-title":"The Prostate"},{"issue":"9","key":"ref7","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1016\/S1470-2045(13)70253-5","article-title":"Hormone-receptor expression and ovarian cancer survival: an Ovarian Tumor Tissue Analysis consortium study","volume":"14","author":"W Sieh","year":"2013","journal-title":"Lancet Oncol. ao\u00fbt"},{"issue":"4","key":"ref8","doi-asserted-by":"crossref","first-page":"1722","DOI":"10.1158\/0008-5472.CAN-09-2612","article-title":"Transcription factor KLF11 integrates progesterone receptor signaling and proliferation in uterine leiomyoma cells","volume":"70","author":"P Yin","year":"2010","journal-title":"Cancer Res"},{"issue":"14","key":"ref9","doi-asserted-by":"crossref","first-page":"6450","DOI":"10.1158\/0008-5472.CAN-04-3087","article-title":"Progesterone receptor in non-small cell lung cancer\u2014a potent prognostic factor and possible target for endocrine therapy","volume":"65","author":"H Ishibashi","year":"2005","journal-title":"Cancer Res"},{"issue":"10\u201311","key":"ref10","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1016\/S0039-128X(00)00193-8","article-title":"Occurrence, regulation, and significance of progesterone receptors in human meningioma","volume":"65","author":"MA Blankenstein","year":"2000","journal-title":"Steroids. nov"},{"issue":"10","key":"ref11","doi-asserted-by":"crossref","first-page":"2543","DOI":"10.1093\/annonc\/mdt216","article-title":"Randomized phase II study of lonaprisan as second-line therapy for progesterone receptor-positive breast cancer","volume":"24","author":"W Jonat","year":"2013","journal-title":"Ann Oncol Off J Eur Soc Med Oncol. oct"},{"issue":"6","key":"ref12","doi-asserted-by":"crossref","first-page":"1736","DOI":"10.1200\/JCO.1999.17.6.1736","article-title":"Oral medroxyprogesterone acetate in the treatment of advanced or recurrent endometrial carcinoma: a dose-response study by the Gynecologic Oncology Group","volume":"17","author":"JT Thigpen","year":"1999","journal-title":"J Clin Oncol Off J Am Soc Clin Oncol"},{"issue":"9","key":"ref13","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1111\/j.1464-410X.2008.07509.x","article-title":"A phase II study of mifepristone (RU-486) in castration-resistant prostate cancer, with a correlative assessment of androgen-related hormones","volume":"101","author":"M-E Taplin","year":"2008","journal-title":"BJU Int"},{"issue":"2","key":"ref14","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1097\/01.AOG.0000223228.23289.0f","article-title":"Mifepristone as treatment of recurrent progesterone receptor-positive uterine leiomyosarcoma","volume":"109","author":"R Koivisto-Korander","year":"2007","journal-title":"Obstet Gynecol"},{"issue":"2","key":"ref15","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1023\/A:1014820500738","article-title":"Loss of co-ordinate expression of progesterone receptors A and B is an early event in breast carcinogenesis","volume":"72","author":"PA Mote","year":"2002","journal-title":"Breast Cancer Res Treat"},{"issue":"3","key":"ref16","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1210\/jc.2003-031111","article-title":"Subnuclear distribution of progesterone receptors A and B in normal and malignant endometrium","volume":"89","author":"RL Arnett-Mansfield","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"issue":"15_suppl","key":"ref17","doi-asserted-by":"crossref","first-page":"5593","DOI":"10.1200\/jco.2015.33.15_suppl.5593","article-title":"Onapristone (ONA) in progesterone receptor (PR)-expressing tumors: Efficacy and biomarker results of a dose-escalation phase 1 study","volume":"33","author":"PH Cottu","year":"2015","journal-title":"J Clin Oncol"},{"issue":"6","key":"ref18","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1093\/nar\/19.6.1227","article-title":"Two types of antiprogestins identified by their differential action in transcriptionally active extracts from T47D cells","volume":"19","author":"L Klein-Hitpass","year":"1991","journal-title":"Nucleic Acids Res"},{"issue":"2","key":"ref19","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1074\/jbc.271.2.1209","article-title":"Two types of anti-progestins have distinct effects on site-specific phosphorylation of human progesterone receptor","volume":"271","author":"CA Beck","year":"1996","journal-title":"J Biol Chem"},{"issue":"1\u20132","key":"ref20","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.jsbmb.2008.11.015","article-title":"Global gene expression profiling of progesterone receptor modulators in T47D cells provides a new classification system","volume":"113","author":"W Afhuppe","year":"2009","journal-title":"J Steroid Biochem Mol Biol"},{"issue":"2","key":"ref21","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1016\/S0015-0282(02)04577-6","article-title":"Progestins activate vascular endothelial growth factor gene transcription in endometrial adenocarcinoma cells","volume":"79","author":"MD Mueller","year":"2003","journal-title":"Fertil Steril"},{"issue":"2","key":"ref22","first-page":"214","article-title":"Onapristone, a progesterone receptor antagonist, as first-line therapy in primary breast cancer","volume":"35","author":"JF Robertson","year":"1999","journal-title":"Eur J Cancer Oxf Engl 1990"},{"key":"ref23","first-page":"117","article-title":"Endocrine Therapy of Breast Cancer","author":"W Jonat","year":"2002"},{"issue":"3","key":"ref24","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1016\/j.ygyno.2015.06.037","article-title":"Development of a technique to detect the activated form of the progesterone receptor and correlation with clinical and histopathological characteristics of endometrioid adenocarcinoma of the uterine corpus","volume":"138","author":"J Bonneterre","year":"2015","journal-title":"Gynecol Oncol"},{"issue":"10\u201313","key":"ref25","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1016\/j.steroids.2003.07.004","article-title":"Effects of onapristone on postmenopausal endometrium","volume":"68","author":"ST Cameron","year":"2003","journal-title":"Steroids. nov"},{"issue":"1","key":"ref26","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1093\/oxfordjournals.humrep.a019032","article-title":"The effects of post-ovulatory administration of onapristone on the developmnent of a secretory endometrium","volume":"11","author":"ST Cameron","year":"1996","journal-title":"Hum Reprod Oxf Engl"},{"issue":"8","key":"ref27","doi-asserted-by":"crossref","first-page":"1442","DOI":"10.1093\/oxfordjournals.humrep.a138726","article-title":"Effect of the antiprogestin onapristone on follicular growth in women","volume":"9","author":"HB Croxatto","year":"1994","journal-title":"Hum Reprod Oxf Engl"},{"issue":"19","key":"ref28","doi-asserted-by":"crossref","first-page":"2221","DOI":"10.1200\/JCO.2014.59.8466","article-title":"Scientific Review of Phase I Protocols With Novel Dose-Escalation Designs: How Much Information Is Needed?","volume":"33","author":"A Iasonos","year":"2015","journal-title":"J Clin Oncol Off J Am Soc Clin Oncol"},{"issue":"15 Supplement","key":"ref29","doi-asserted-by":"crossref","first-page":"4523","DOI":"10.1158\/1538-7445.AM2015-4523","article-title":"Abstract 4523: Population pharmacokinetic (PPK) modeling of onapristone in patients (pts) with progesterone receptor (PR)-expressing cancers","volume":"75","author":"K Rezai","year":"2015","journal-title":"Cancer Res"},{"issue":"1","key":"ref30","doi-asserted-by":"crossref","first-page":"R15","DOI":"10.1530\/REP-14-0416","article-title":"Antiprogestins in gynecological diseases","volume":"149","author":"AA Goyeneche","year":"2015","journal-title":"Reprod Camb Engl"},{"issue":"3","key":"ref31","doi-asserted-by":"crossref","first-page":"R35","DOI":"10.1530\/ERC-11-0378","article-title":"Antiprogestins in breast cancer treatment: are we ready?","volume":"19","author":"C Lanari","year":"2012","journal-title":"Endocr Relat Cancer"},{"issue":"10","key":"ref32","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1517\/14656566.2014.914494","article-title":"Selective progesterone receptor modulators: an update","volume":"15","author":"G Benagiano","year":"2014","journal-title":"Expert Opin Pharmacother"},{"issue":"10\u201311","key":"ref33","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1016\/S0039-128X(00)00195-1","article-title":"Progesterone antagonists and progesterone receptor modulators in the treatment of breast cancer","volume":"65","author":"JG Klijn","year":"2000","journal-title":"Steroids. nov"},{"issue":"7560","key":"ref34","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1038\/nature14583","article-title":"Progesterone receptor modulates ERalpha action in breast cancer","volume":"523","author":"H Mohammed","year":"2015","journal-title":"Nature"},{"issue":"9","key":"ref35","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1016\/S0344-0338(11)80674-6","article-title":"Reproducibility of subjective immunohistochemical estrogen- and progesterone receptor determination in human endometrium","volume":"189","author":"V Ravn","year":"1993","journal-title":"Pathol Res Pract. nov"},{"issue":"1","key":"ref36","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1309\/4WV79N2GHJ3X1841","article-title":"Immunohistochemistry of estrogen and progesterone receptors reconsidered: experience with 5,993 breast cancers","volume":"123","author":"M Nadji","year":"2005","journal-title":"Am J Clin Pathol"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0204973","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,5]],"date-time":"2023-09-05T21:43:19Z","timestamp":1693950199000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0204973"}},"subtitle":[],"editor":[{"given":"Denis","family":"Alferez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2018,10,10]]},"references-count":36,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2018,10,10]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0204973","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,10,10]]}}}